KPMG study: Digitalization in life sciences

Using digital technologies for personalized therapy: We asked 75 senior managers from the life sciences industry about their progress on their digitalization journeys. The study highlights innovative use cases and compelling, real-world examples of digitalization in life sciences.

14845_Studie_KPMG_Digitalization life sciences_BF_sec_Seite_01.jpg

 

The patient is taking center stage. And life sciences companies need to react. They need to move from being a supplier of a single drug to creating individual patient-specific treatments. This requires them to develop a digital strategy along the entire value chain. This is one of the key findings of the KPMG study "Digitalization in life sciences - Integrating the patient pathway into the technology ecosystem".

The study discusses how digitalization can improve the efficiency of core processes and also help to make life sciences companies an integral part of patient care pathways. It looks at how artificial intelligence, automation, blockchain and other technologies can support companies on this journey.